SCHEMBL8246771

SCHEMBL8246771

CCCCOc1ccc(CC(CO)NC(=O)CCl)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACACB O00763 5/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
PDE4A P27815 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HIF1A Q16665 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
CNR1 P21554 1/20 0.47
ITGB3 P05106 2/20 0.47
ITGA2B P08514 2/20 0.47
ITGB1 P05556 1/20 0.47
ITGA4 P13612 1/20 0.47
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
LPAR3 Q9UBY5 3/20 0.45
LPAR1 Q92633 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4774975 0.84 LDHA (0.50) ACACBSMN1; SMN2ALDH1A1
SCHEMBL29197625 0.84 LDHA (0.50) ACACBSMN1; SMN2ALDH1A1
SCHEMBL16766937 0.84 LDHA (0.50) ACACBSMN1; SMN2ALDH1A1
SCHEMBL13854963 0.82 ACACB (0.48) ACACBKDM4ECYP1A2CYP2D6PDE4A
SCHEMBL12739543 0.82 ITGB3 (0.58) ITGB3ITGA2BLMNALPAR3LPAR1
SCHEMBL4230149 0.81 PPARG (0.51) SMN1; SMN2ALDH1A1LPAR3LPAR1
SCHEMBL8246768 0.80 ITGB3 (0.56) ACACBKDM4ECYP1A2CYP2D6PDE4A
SCHEMBL14051416 0.80 ITGB3 (0.56) ACACBKDM4ECYP1A2CYP2D6PDE4A
SCHEMBL17935577 0.79 ACACB (0.48) ACACBKDM4ECYP1A2CYP2D6PDE4A
SCHEMBL14543355 0.79 ACACB (0.48) ACACBKDM4ECYP1A2CYP2D6PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090131420-A1 Novel Heterocyclic Analogs of Biphenyl Ethers ORCHID RESEARCH LABORATORIES, LTD. (IN) 2009-05-21 US disclosed
US-20080267888-A1 Heterocyclic Derivatives ORCHID RESEARCH LABORATORIES LIMITED (IN) 2008-10-30 US disclosed
WO-2007042878-A1 NOVEL HETEROCYCLIC ANALOGS OF BIPHENYL ETHERS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2007-04-19 WO disclosed
WO-2006126074-A2 HETEROCYCLIC DERIVATIVES ORCHID RESEARCH LABORATORIES LIMITED (IN) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080267888-A1 Heterocyclic Derivatives CYP11B2, MAPT, UGT1A1 ACACB 2452/4885KDM4E 4138/4885CYP1A2 29/4885
US-20090131420-A1 Novel Heterocyclic Analogs of Biphenyl Ethers UGT2B7, CYP4B1, CYP1B1 ACACB 1712/4885KDM4E 329/4885CYP1A2 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.